This federal contract award, valued at $33,760.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,149,261 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $4,104.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,419,982 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a...
This federal contract award, valued at $3,069.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,062,083 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 29, 2025. The contract is not set-aside and is open to competition....
This federal contract award, valued at $2,948.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,014,396 units of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $16,782.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,966,829 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $13,518.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,073,388 units of the medication Ondansetron ODT 4 mg tablet, a drug used to treat nausea and vomiting. The contract has a firm fixed-price pricing type and an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $7,379.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, worth $7,798.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,153,745 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. This is a firm-fixed-price delivery order contract, with a completion date of February 5, 2025. The contract is not designated as a set-aside award. In addition to...
The federal contract award, valued at $13,437.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,603.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,059 units of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. This is a Firm Fixed Price Delivery Order contract with a completion date of January 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...